| NCT ID | NCT07236034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Vaccination |
| Study Type | INTERVENTIONAL |
| Enrollment | 700 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 700 participants in total. It began in 2025-12-01 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal is to identify the most impactful strategies for capturing attention and enhancing effectiveness of vaccine promotion messages. This will be done using an online survey that employs remote eye-tracking and self report measures to evaluate response to sample vaccine promotion social media content in rural populations in New England. Participants will be randomly assigned into one of 14 conditions in a 2(source: expert vs. influencer) by 7 (themes: constructs from 7C Vaccine Framework) experiment and view sample messages and then answer questions about their attitudes and beliefs while being monitored for eye-tracking.
Eligibility Criteria
Inclusion Criteria: * Age 18+ * Living in New England state (CT, MA, ME, NH, VT RI) in a zip code as defined by each individual state's definition of rural * Able to read and write in English * Access to an internet connected computer or laptop with a web-camera Exclusion Criteria: * N/A
Contact & Investigator
Grace W Ryan, PhD, MPH
PRINCIPAL INVESTIGATOR
University of Massachusetts, Worcester
Frequently Asked Questions
Who can join the NCT07236034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Vaccination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07236034 currently recruiting?
Yes, NCT07236034 is actively recruiting participants. Contact the research team at grace.ryan1@umassmed.edu for enrollment information.
Where is the NCT07236034 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT07236034 clinical trial?
NCT07236034 is sponsored by University of Massachusetts, Worcester. The principal investigator is Grace W Ryan, PhD, MPH at University of Massachusetts, Worcester. The trial plans to enroll 700 participants.